Handbrake on hysterectomy: Developing a personalised and fertility sparing pharmacological therapy for uterine fibroid-induced symptoms

MRC · United Kingdom government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Fibroids are common non-cancerous tumours of the uterine wall affecting millions of women of childbearing age around the world. They cause heavy menstrual bleeding (HMB), subfertility and exert pressure on the adjacent organs, making women feel pain and discomfort. The prevalence increases with age and 1 in 2 women have fibroids by 50 years. One in four women experience HMB, which reduces quality of life; women may not be able to manage the activities in their day-to-day lives, perform well in their education or job, and have difficulties in their personal and family life due to symptoms caused by fibroids. Although common, there are no curative treatments for fibroids that preserve the uterus and thus, fertility, and many women undergo hysterectomy for this indication. In fact, fibroids are the main reason for hysterectomy in the world. Many women delay their childbearing until later in life, thus, fibroids being more prevalent with age cause severe symptoms and hysterectomy will prevent them conceiving. Finding fertility-sparing medical treatments that stops the growth of fibroids until menopause will improve the quality of life of millions of women, and reduce the morbidity and mortality associated with risky major surgery.
Angiogenesis is essential for fibroid growth and uterine cellular ageing and age-associated hormonal imbalance are proposed yet understudied mechanisms that initiate fibroid growth.
Aim: This PhD studentship seeks to improve our understanding of how different each fibroid is, both in the same woman and between women, to understand why they do not all respond to available treatments in the same way. It also aims to identify druggable targets to develop future novel treatments.

Environment and learning experience: The successful student will be taught latest state-of-the-art techniques at a multi-omics level. Combining transcriptomics, quantitative proteomics and advance data integration and data science techniques and will provide insights on...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Global Travel, Accommodation and Venue Management Services
NEPRO Total Talent
Capital Programme Delivery Framework(s)
Technology Products and Associated Services 3
Technology Products and Associated Services 3
Workforce Solution 2
GMCA 2201 NW Regional Children’s Services Contract
Integrated Partnerships Framework

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.